82 related articles for article (PubMed ID: 399187)
1. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
[TBL] [Abstract][Full Text] [Related]
2. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Gragnoli G; Tanganelli I; Signorini AM
Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
[TBL] [Abstract][Full Text] [Related]
4. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic beta cell function in offspring of conjugal diabetic parents. Assessment by IRI and C-peptide ratio.
Snehalatha C; Mohan V; Ramachandran A; Jayashree R; Viswanathan M
Horm Metab Res; 1984 Dec; 16 Suppl 1():142-4. PubMed ID: 6398253
[TBL] [Abstract][Full Text] [Related]
6. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
[TBL] [Abstract][Full Text] [Related]
7. Stepwise increase in plasma insulin and C-peptide concentrations in obese, in obese hypertensive, and in obese hypertensive diabetic subjects.
Donatelli M; Scarpinato A; Bucalo ML; Russo V; Iraci T; Vassallo G
Diabetes Res; 1991 Jul; 17(3):125-9. PubMed ID: 1841027
[TBL] [Abstract][Full Text] [Related]
8. Studies of glucose intolerance in cirrhosis of the liver.
Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
[TBL] [Abstract][Full Text] [Related]
9. [Serum prolactin in obese subjects with glucose intolerance before and after treatment with phenformin].
Pata P; Smedile G; Morabito S; Mancuso TR; Arcoraci A
Boll Soc Ital Biol Sper; 1981 Mar; 57(5):522-5. PubMed ID: 7020721
[TBL] [Abstract][Full Text] [Related]
10. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
[TBL] [Abstract][Full Text] [Related]
11. Hepatic extraction of insulin in non-insulin dependent diabetes. Comparative study of obese and non-obese patients.
Snehalatha C; Mohan V; Ramachandran A; Jayashree R; Viswanathan M
Diabete Metab; 1984 Sep; 10(3):175-80. PubMed ID: 6386556
[TBL] [Abstract][Full Text] [Related]
12. Glucose, immunoreactive insulin and C-peptide immunoreactivity in patients with acute viral hepatitis.
Scremin S; Caprioglio L; D'Aquino M; Virgili F; Fabbro A; Okolicsanyi L
Horm Metab Res; 1983 Jul; 15(7):313-6. PubMed ID: 6350137
[TBL] [Abstract][Full Text] [Related]
13. Insulin metabolism in hypothalamic obesity.
Blatniczky L; Kautzky L; Péter F
Exp Clin Endocrinol; 1990 Sep; 96(1):83-9. PubMed ID: 2279530
[TBL] [Abstract][Full Text] [Related]
14. [Increase of circulating levels of insulin and C-peptide: common factors in essential hypertension and overweight].
Sechi LA; Tedde R; Melis A; Pala A; Marigliano A; Orecchioni C; Pisanu G; Bartoli E
Ann Ital Med Int; 1990; 5(4 Pt 1):348-52. PubMed ID: 2093360
[TBL] [Abstract][Full Text] [Related]
15. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
[TBL] [Abstract][Full Text] [Related]
16. Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children.
Baldelli R; Bellone S; Castellino N; Petri A; Rapa A; Vivenza D; Bellone J; Broglio F; Ghigo E; Bona G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):255-9. PubMed ID: 16487433
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between plasma insulin and C peptide and mild and severe obesity].
García Pascual IJ; González Ruiz JM
An Med Interna; 1993 Nov; 10(11):526-31. PubMed ID: 8117866
[TBL] [Abstract][Full Text] [Related]
18. Naloxone effects on post-prandial glucose, insulin and C-peptide levels in obese subjects.
De Marinis L; Mancini A; De Luca AM; Fiumara C; Zuppi P; Sammartano L; Valle D
Diabetes Res; 1993; 23(2):83-91. PubMed ID: 7712683
[TBL] [Abstract][Full Text] [Related]
19. [Insulin metabolism in obese children tested by oral and intravenous glucose loading].
Blatniczky L; Halász Z
Orv Hetil; 1989 Oct; 130(44):2357-61. PubMed ID: 2682447
[TBL] [Abstract][Full Text] [Related]
20. Zinc status in plasma of obese individuals during glucose administration.
Chen MD; Lin PY; Sheu WH
Biol Trace Elem Res; 1997; 60(1-2):123-9. PubMed ID: 9404681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
